Mark L. Pacala, Director of Starling Oncology STLN, has filed 1 purchase and 3 sales on the open market. Over the past 12 months that comes to a net sale of $200K. The latest trade was on 25/11/20.

MP

MP

Mark L. Pacala

Director

Company

Starling Oncology STLN

First filing

23/03/21

Trades

12 trades

Buys / sales

1 / 3

12-month net buying

−$200K

Last trade

25/11/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Starling OncologySTLN	Open-market sale	25/11/18	25/11/20	50,000 sh3 trades	$4.00avg.	$200,000	−22.2%
Starling OncologySTLN	Open-market buy	25/03/26	25/03/28	90,562 sh	$1.04	$94,184.48	+67.4%